Bruck Claudine
Insider CIK 1733680 · ANVS Director · NAVB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ANVS Annovis Bio, Inc. | M Exercise deriv | 2025-09-10 | 2025-11-12 | 7,142 | — | $0 | 0 | SEC↗ |
| ANVS Annovis Bio, Inc. | M Exercise | 2025-09-10 | 2025-11-12 | 7,142 | $0.14 | $1000 | 13,709 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2023-11-20 | 2023-11-21 | 1,000 | $6.07 | $6.1K | 7,567 | SEC↗ |
| ANVS Annovis Bio, Inc. | J Other | 2023-11-20 | 2023-11-22 | 0 | — | $0 | 6,567 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2023-11-17 | 2024-07-03 | 26,200 | — | $0 | 26,200 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award | 2023-04-07 | 2023-04-11 | 500 | $12.61 | $6.3K | 6,567 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2023-01-18 | 2023-01-20 | 5,967 | — | $0 | 5,967 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2021-10-11 | 2021-10-13 | 181 | $27.66 | $5.0K | 6,067 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2021-07-07 | 2021-07-09 | 4,000 | — | $0 | 4,000 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2021-06-30 | 2021-07-07 | 3,969 | — | $0 | 16,519 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award deriv | 2021-01-13 | 2021-01-14 | 2,500 | — | $0 | 2,500 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2021-01-13 | 2021-01-14 | 2,500 | — | $0 | 12,550 | SEC↗ |
| ANVS Annovis Bio, Inc. | A Award deriv | 2020-07-01 | 2020-07-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award deriv | 2020-02-06 | 2020-02-07 | 2,500 | — | $0 | 7,500 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2020-02-06 | 2020-02-07 | 2,500 | — | $0 | 10,050 | SEC↗ |
| ANVS Annovis Bio, Inc. | C Conversion deriv | 2020-01-31 | 2020-02-05 | 1,117 | $4.80 | $5.4K | 0 | SEC↗ |
| ANVS Annovis Bio, Inc. | C Conversion deriv | 2020-01-31 | 2020-02-05 | 5,556 | — | $0 | 0 | SEC↗ |
| ANVS Annovis Bio, Inc. | C Conversion | 2020-01-31 | 2020-02-05 | 3,969 | — | $0 | 4,769 | SEC↗ |
| ANVS Annovis Bio, Inc. | C Conversion | 2020-01-31 | 2020-02-05 | 1,117 | $4.80 | $5.4K | 5,886 | SEC↗ |
| ANVS Annovis Bio, Inc. | P Buy | 2020-01-31 | 2020-02-05 | 800 | $6.00 | $4.8K | 800 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | P Buy | 2019-05-13 | 2019-05-15 | 2,550 | $1.90 | $4.8K | 7,550 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award deriv | 2019-02-07 | 2019-02-12 | 50,000 | — | $0 | 100,000 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2019-02-07 | 2019-02-12 | 50,000 | — | $0 | 100,000 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award deriv | 2018-03-15 | 2018-03-16 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2018-03-15 | 2018-03-16 | 50,000 | — | $0 | 50,000 | SEC↗ |